Cortical myoclonic tremor after chimeric antigen receptor T-cell therapy.

Swinnen, Bart E K S; van Rootselaar, Anne-Fleur; Spanjaart, Anne M; de Bie, Rob M A; Kersten, Marie J; van de Beek, Diederik; Brouwer, Matthijs C; Dijk, Joke M

Swinnen, Bart E K S; van Rootselaar, Anne-Fleur; Spanjaart, Anne M; de Bie, Rob M A; Kersten, Marie J; van de Beek, Diederik; Brouwer, Matthijs C; Dijk, Joke M.

Afiliación

Swinnen BEKS; Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam UMC, PO Box 22660, 1100DD, Amsterdam, The Netherlands. b.e.k.swinnen@amsterdamumc.nl.
van Rootselaar AF; Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam UMC, PO Box 22660, 1100DD, Amsterdam, The Netherlands.
Spanjaart AM; Clinical Neurophysiology, Amsterdam Neuroscience, University of Amsterdam, Amsterdam UMC, PO Box 22660, 1100DD, Amsterdam, The Netherlands.
de Bie RMA; Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Kersten MJ; LYMMCARE, Amsterdam, The Netherlands.
van de Beek D; Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam UMC, PO Box 22660, 1100DD, Amsterdam, The Netherlands.
Brouwer MC; Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Dijk JM; LYMMCARE, Amsterdam, The Netherlands.

J Neurol ; 269(9): 5165-5169, 2022 09.

Article en En | MEDLINE | ID: mdl-35403878

Asunto(s)

Epilepsias Mioclónicas; Mioclonía; Receptores Quiméricos de Antígenos; Tratamiento Basado en Trasplante de Células y Tejidos; Humanos; Temblor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Epilepsias Mioclónicas / Receptores Quiméricos de Antígenos / Mioclonía Límite: Humans Idioma: En Revista: J Neurol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google